Matrix metalloproteinase-2 in the development of diabetic retinopathy and mitochondrial dysfunction.
about
Microvascular complications and diabetic retinopathy: recent advances and future implicationsTherapeutic effect of bone marrow mesenchymal stem cells on laser-induced retinal injury in miceMatrix metalloproteinase 2 contributes to pancreatic Beta cell injury induced by oxidative stress.Epigenetic modifications of Keap1 regulate its interaction with the protective factor Nrf2 in the development of diabetic retinopathyMacrophage metalloelastase (MMP-12) deficiency mitigates retinal inflammation and pathological angiogenesis in ischemic retinopathy.The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy.Epigenetic changes in mitochondrial superoxide dismutase in the retina and the development of diabetic retinopathy.Novel role of mitochondrial matrix metalloproteinase-2 in the development of diabetic retinopathyPlasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications StudyAbrogation of MMP-9 gene protects against the development of retinopathy in diabetic mice by preventing mitochondrial damage.Loss of survival factors and activation of inflammatory cascades in brain sympathetic centers in type 1 diabetic mice.Mitochondrial biogenesis and the development of diabetic retinopathyDiabetic retinopathy, superoxide damage and antioxidants.Inhibition of the adrenomedullin/nitric oxide signaling pathway in early diabetic retinopathy.Interleukin-1β and mitochondria damage, and the development of diabetic retinopathy.Damaged mitochondrial DNA replication system and the development of diabetic retinopathy.Connective tissue growth factor regulates retinal neovascularization through p53 protein-dependent transactivation of the matrix metalloproteinase (MMP)-2 geneRole of matrix metalloproteinase-2 and -9 in the development of diabetic retinopathyA compensatory mechanism protects retinal mitochondria from initial insult in diabetic retinopathyRegulation of matrix metalloproteinase-9 by epigenetic modifications and the development of diabetic retinopathy.Diabetic retinopathy and signaling mechanism for activation of matrix metalloproteinase-9Matrix metalloproteinases in diabetic retinopathy: potential role of MMP-9.VEGF secreted by hypoxic Müller cells induces MMP-2 expression and activity in endothelial cells to promote retinal neovascularization in proliferative diabetic retinopathy.Poly (ADP-ribose) polymerase mediates diabetes-induced retinal neuropathy.Interrelationship between activation of matrix metalloproteinases and mitochondrial dysfunction in the development of diabetic retinopathy.Oxidative stress and reactive oxygen species: a review of their role in ocular disease.Crosstalk Between Histone and DNA Methylation in Regulation of Retinal Matrix Metalloproteinase-9 in Diabetes.The Role of Microglia in Diabetic Retinopathy: Inflammation, Microvasculature Defects and Neurodegeneration.Therapeutic targets for altering mitochondrial dysfunction associated with diabetic retinopathy.Sirt1- A Guardian of the Development of Diabetic Retinopathy.Role of PARP-1 as a novel transcriptional regulator of MMP-9 in diabetic retinopathy.Effects of alpha-lipoic acid on retinal ganglion cells, retinal thicknesses, and VEGF production in an experimental model of diabetes.Molecular Mechanism of Transcriptional Regulation of Matrix Metalloproteinase-9 in Diabetic Retinopathy.
P2860
Q26822476-7664D7EE-46E0-4CBD-B78E-256286E3DCA7Q33907492-F1743DBC-6B24-41D3-8104-D71F4E60C7DAQ34344202-5F24C127-30DC-4A2E-9BC0-5AEF0FDECED6Q34511162-7CAE59F0-4D19-4487-8C8E-D0FA6A4152C1Q34534458-2B0B58C4-FCB6-402E-8AA9-DF2960931C26Q34645612-242BFDC4-8FF6-4B78-AFF6-5157A9E2A375Q34718901-288B9784-926F-4C59-BF2A-225CB6221A2CQ35027703-1FB2D507-C20D-4E37-AF4D-B491FF8CCBE2Q35166512-E2FD4895-A93E-4C45-A603-40629510E9CFQ35404674-7F4D913A-FFD9-40AF-A901-413554DE903DQ35436829-6A0D3C58-740F-4457-B752-F8691C9E4747Q35457777-85E046EC-A21C-4E9C-A302-28A11B3EC5BFQ35545811-086516D0-E52B-4D14-AEF6-64B7152C48D3Q35928442-4D8F6FB8-4FBC-4109-BF9F-AEBCF2DC2BE6Q35928454-FA5BBCE3-3A8C-4939-9FC5-FCD926666E2EQ36001839-2FBCCEC0-F423-4A78-8C44-232CAE740E78Q36418892-3BA8FBDD-A252-469A-9964-0FF4CBB52A60Q36468930-DE910AC1-196F-4680-A5E7-DBC111453ED9Q36783430-8B7A4079-B18B-4B89-96C2-7B6C7FEDF465Q37015005-0885F59C-AACB-4AF4-8463-08FCFCB5FB92Q37241389-75421AE5-080E-4049-8CFE-0903F361759EQ37242419-7D925486-B797-4656-AEF8-29C91F31AF71Q37251091-0434F44D-A367-4BFF-87BA-3406EA24B996Q37379837-83C60747-437F-4921-8055-E9D20111E0C1Q37396370-33EC8FD8-B997-4D16-84EF-816EFD4ED1CDQ46248374-51D967D6-33D7-471F-9626-593F63DF9AA8Q47122605-6FF0909B-0425-43A0-AD48-5624005EC49BQ48308877-67059970-50DE-40DF-A790-38893A9EA48BQ50049076-E3476A64-D30D-4737-AFD0-C927973E423DQ50133670-D276C23C-08FC-4E7E-8AA0-E5424DEE817BQ51016986-DDE29090-9376-4B7B-827D-D28342143418Q51325462-486D6F4D-7640-4053-A4D0-73925BF0B23EQ53266552-AF820A0D-C86E-4F8A-9EF3-5F632C63A39E
P2860
Matrix metalloproteinase-2 in the development of diabetic retinopathy and mitochondrial dysfunction.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Matrix metalloproteinase-2 in ...... and mitochondrial dysfunction.
@ast
Matrix metalloproteinase-2 in ...... and mitochondrial dysfunction.
@en
Matrix metalloproteinase-2 in ...... and mitochondrial dysfunction.
@nl
type
label
Matrix metalloproteinase-2 in ...... and mitochondrial dysfunction.
@ast
Matrix metalloproteinase-2 in ...... and mitochondrial dysfunction.
@en
Matrix metalloproteinase-2 in ...... and mitochondrial dysfunction.
@nl
prefLabel
Matrix metalloproteinase-2 in ...... and mitochondrial dysfunction.
@ast
Matrix metalloproteinase-2 in ...... and mitochondrial dysfunction.
@en
Matrix metalloproteinase-2 in ...... and mitochondrial dysfunction.
@nl
P2860
P1476
Matrix metalloproteinase-2 in ...... and mitochondrial dysfunction.
@en
P2093
Ghulam Mohammad
Renu A Kowluru
P2860
P2888
P304
P356
10.1038/LABINVEST.2010.89
P577
2010-05-17T00:00:00Z
P5875
P6179
1044024340